Search Within

Phillip Wong

Formats
  1. Journal Article (49)
  2. Meeting Abstract (32)
  3. Research Letter (1)
Groups
  1. Department of Medicine (80)
  2. Solid Tumor Oncology Division (66)
  3. GSK Faculty (55)
  4. Melanoma and Immunotherapeutics Service (43)
  5. Epidemiology and Biostatistics (33)
  6. Biostatistics Service (32)

More Groups

People
  1. Jedd Wolchok (38)
  2. Jianda Yuan (21)
  3. Michael Postow (18)
  4. Taha Merghoub (16)
  5. Margaret Callahan (14)
  6. Matthew Adamow (12)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Clinical Cancer Research (8)
  3. Journal for ImmunoTherapy of Cancer (8)
  4. Annals of Oncology (3)
  5. Blood (3)
  6. Cancer Immunology Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (14)
  3. Nature Publishing Group (9)
  4. Biomed Central Ltd (8)
  5. Cell Press (5)
  6. Elsevier Inc. (4)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interrogation of neoantigen-specific CD8 T cells in peripheral blood following PD-L1 blockade in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Holm, J. S.; Funt, S. A.; Bjerregaard, A. M.; Reading, J. L.; Maher, C. A.; Regazzi, A. M.; Wong, P.; Al-Ahmadie, H.; Overgaard, N. H.; Tamhane, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Overcoming immune resistance with rationally designed combination immunotherapy
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
    Journal Article

    Zviran, A.; Schulman, R. C.; Shah, M.; Hill, S. T. K.; Deochand, S.; Khamnei, C. C.; Maloney, D.; Patel, K.; Liao, W.; Widman, A. J.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma
    Journal Article

    Postow, M. A.; Knox, S. J.; Goldman, D. A.; Elhanati, Y.; Mavinkurve, V.; Wong, P.; Halpenny, D.; Reddy, S. K.; Vado, K.; McCabe, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Rational combination of GITR agonism with PD-1 blockade
    Meeting Abstract

    Zappasodi, R.; Sirard, C.; Li, Y.; Budhu, S.; Abu-Akeel, M.; Liu, C.; Yang, X.; Zhong, H.; Newman, W.; Qi, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance
    Journal Article

    Verma, V.; Shrimali, R. K.; Ahmad, S.; Dai, W.; Wang, H.; Lu, S.; Nandre, R.; Gaur, P.; Lopez, J.; Sade-Feldman, M.; more...
    Nature Immunology (2019)

    Fulltext@MSK | Save